ISIN | CH0137596661 |
---|---|
Valor Number | 13759666 |
Bloomberg Global ID | BBG0025YH505 |
Fund Name | Bellevue Healthcare Strategy I |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 3,621.49 CHF | 07.11.2024 |
---|---|---|
Previous Price * | 3,596.63 CHF | 06.11.2024 |
52 Week High * | 3,708.66 CHF | 30.08.2024 |
52 Week Low * | 3,270.90 CHF | 28.12.2023 |
NAV * | 3,621.49 CHF | 07.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 198,240,151 | |
Unit/Share Assets *** | 99,104,959 | |
Trading Information SIX |
YTD Performance | +10.05% |
29.12.2023 - 07.11.2024
29.12.2023 07.11.2024 |
---|---|---|
1 month | +1.07% |
07.10.2024 - 07.11.2024
07.10.2024 07.11.2024 |
3 months | +3.32% |
07.08.2024 - 07.11.2024
07.08.2024 07.11.2024 |
6 months | +0.49% |
07.05.2024 - 07.11.2024
07.05.2024 07.11.2024 |
1 year | +8.34% |
07.11.2023 - 07.11.2024
07.11.2023 07.11.2024 |
2 years | -2.09% |
07.11.2022 - 07.11.2024
07.11.2022 07.11.2024 |
3 years | -11.33% |
08.11.2021 - 07.11.2024
08.11.2021 07.11.2024 |
5 years | +19.56% |
07.11.2019 - 07.11.2024
07.11.2019 07.11.2024 |
Equity Participation Rate in % | 94.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 07.11.2024 |
Eli Lilly and Co | 3.44% | |
---|---|---|
Regeneron Pharmaceuticals Inc | 3.33% | |
HCA Healthcare Inc | 3.30% | |
Vertex Pharmaceuticals Inc | 3.15% | |
Insulet Corp | 3.02% | |
Boston Scientific Corp | 3.01% | |
UCB SA | 2.99% | |
UnitedHealth Group Inc | 2.96% | |
Stryker Corp | 2.77% | |
IQVIA Holdings Inc | 2.73% | |
Last data update | 31.08.2024 |
TER | 0.81% |
---|---|
TER date | 29.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |